These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The investigation of experimental brain tumours using 31P-MRS and 1H-MRI. Hirakawa K; Naruse S; Higuchi T; Horikawa Y; Tanaka C; Ebisu T Acta Neurochir Suppl (Wien); 1988; 43():140-4. PubMed ID: 3213641 [TBL] [Abstract][Full Text] [Related]
44. In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene. Auricchio A; Zhou R; Wilson JM; Glickson JD Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5205-10. PubMed ID: 11296261 [TBL] [Abstract][Full Text] [Related]
45. Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor. Paulsen JE; Elgjo K In Vivo; 2001; 15(5):397-401. PubMed ID: 11695236 [TBL] [Abstract][Full Text] [Related]
46. Age-related changes in swine brain creatine kinase-catalyzed 31P exchange measured in vivo using 31P NMR magnetization transfer. Corbett RJ; Laptook AR J Cereb Blood Flow Metab; 1994 Nov; 14(6):1070-7. PubMed ID: 7929650 [TBL] [Abstract][Full Text] [Related]
47. Critical role of phosphagens in the energy cascade of cutaneous ischemia and protective action of phosphocreatine analogues in skin flap survival. Cuono CB; Marquetand R; Klein MB; Armitage I Plast Reconstr Surg; 1998 May; 101(6):1597-603. PubMed ID: 9583491 [TBL] [Abstract][Full Text] [Related]
48. Characterization of cerebral white matter damage in preterm infants using 1H and 31P magnetic resonance spectroscopy. Robertson NJ; Kuint J; Counsell TJ; Rutherford TA; Coutts A; Cox IJ; Edwards AD J Cereb Blood Flow Metab; 2000 Oct; 20(10):1446-56. PubMed ID: 11043907 [TBL] [Abstract][Full Text] [Related]
49. Free ADP levels in transgenic mouse liver expressing creatine kinase. Effects of enzyme activity, phosphagen type, and substrate concentration. Brosnan MJ; Chen L; Van Dyke TA; Koretsky AP J Biol Chem; 1990 Dec; 265(34):20849-55. PubMed ID: 2249991 [TBL] [Abstract][Full Text] [Related]
50. 13C- and 31P-NMR studies of human colon cancer in-vitro and in-vivo. Singer S; Okunieff P; Gostin C; Thilly WG; Chen LB; Neuringer LJ Surg Oncol; 1993; 2(1):7-18. PubMed ID: 8252195 [TBL] [Abstract][Full Text] [Related]
51. In vivo development of brain phosphocreatine in normal and creatine-treated rabbit pups. Holtzman D; Khait I; Mulkern R; Allred E; Rand T; Jensen F; Kraft R J Neurochem; 1999 Dec; 73(6):2477-84. PubMed ID: 10582608 [TBL] [Abstract][Full Text] [Related]
52. Proton magnetic resonance spectroscopic creatine correlates with creatine transporter protein density in rat brain. Sartorius A; Lugenbiel P; Mahlstedt MM; Ende G; Schloss P; Vollmayr B J Neurosci Methods; 2008 Jul; 172(2):215-9. PubMed ID: 18555535 [TBL] [Abstract][Full Text] [Related]
53. Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts. Gorshkov K; Wang AQ; Sun W; Fisher E; Frigeni M; Singleton M; Thorne N; Class B; Huang W; Longo N; Do MT; Ottinger EA; Xu X; Zheng W Pharmacol Res Perspect; 2019 Dec; 7(6):e00525. PubMed ID: 31859463 [TBL] [Abstract][Full Text] [Related]
54. Phosphorus metabolite characterization of human prostatic adenocarcinoma in a nude mouse model by 31P magnetic resonance spectroscopy and high pressure liquid chromatography. Kurhanewicz J; Dahiya R; Macdonald JM; Jajodia P; Chang LH; James TL; Narayan P NMR Biomed; 1992; 5(4):185-92. PubMed ID: 1449954 [TBL] [Abstract][Full Text] [Related]
55. Gated dynamic 31P MRS shows reduced contractile phosphocreatine breakdown in mice deficient in cytosolic creatine kinase and adenylate kinase. Kan HE; Veltien A; Arnts H; Nabuurs CI; Luijten B; de Haan A; Wieringa B; Heerschap A NMR Biomed; 2009 Jun; 22(5):523-31. PubMed ID: 19156695 [TBL] [Abstract][Full Text] [Related]
56. Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity. Tortora G; Caputo R; Damiano V; Caputo R; Troiani T; Veneziani BM; De Placido S; Bianco AR; Zangemeister-Wittke U; Ciardiello F Clin Cancer Res; 2003 Feb; 9(2):866-71. PubMed ID: 12576461 [TBL] [Abstract][Full Text] [Related]
57. Protective effect of creatine against inhibition by methylglyoxal of mitochondrial respiration of cardiac cells. Roy SS; Biswas S; Ray M; Ray S Biochem J; 2003 Jun; 372(Pt 2):661-9. PubMed ID: 12605598 [TBL] [Abstract][Full Text] [Related]
58. Microtubule stabilization and potentiation of taxol activity by the creatine analog cyclocreatine. Martin KJ; Vassallo CD; Teicher BA; Kaddurah-Daouk R Anticancer Drugs; 1995 Jun; 6(3):419-26. PubMed ID: 7670140 [TBL] [Abstract][Full Text] [Related]
59. Myocellular creatine and creatine transporter serine phosphorylation after starvation. Zhao CR; Shang L; Wang W; Jacobs DO J Surg Res; 2002 Jun; 105(1):10-6. PubMed ID: 12069495 [TBL] [Abstract][Full Text] [Related]
60. Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism. Ara G; Gravelin LM; Kaddurah-Daouk R; Teicher BA In Vivo; 1998; 12(2):223-31. PubMed ID: 9627806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]